Lygos
PrivateLast Round
Convertible Debt
Apr 18, 2022
Total Funding Raised
$206.37M
Company Overview
Lygos is a biotechnology company that engineers microbes to convert plant-based sugars into high-value, bio-based specialty chemicals and polymers.
Sector
Energy & Sustainability
Verticals
Biotechnology, Sustainable Materials, Advanced Materials, Clean Manufacturing
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Lygos Comparables
Compare Lygos with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| DMC Biotechnologies | 80% | |
| Ecovia Bio | 79% | |
| Manus Bio | 77% | |
Lygos Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Convertible Debt | Apr 18, 2022 | ||||
| Strategic | Feb 9, 2021 | ||||
| Series B Extension | Sep 16, 2019 | ||||
| Grant | Jun 3, 2019 | ||||
| Grant | Mar 11, 2019 | ||||
Series B Extension | Jan 24, 2019 |
Key People
Founding team and executive leadership
Lygos Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Vast Ventures | Series A |
| LG Technology Ventures | Series B, Series B Extension |
| IA Ventures | Series B, Series A |
| First Round Capital | Series A, Series B |
| Vast Ventures | Series A |
| Y Combinator | Seed |
| OS Fund | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 5, 2025
Added IndSpyre Solutions, Inc. from the Chemicals industry.
- May 6, 2024
Collaboration with CJ Bio to build a biorefinery in Iowa.
Lygos Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Lygos's valuation, stock price, and market status.